Journal
CURRENT STEM CELL RESEARCH & THERAPY
Volume 9, Issue 5, Pages 424-431Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1574888X09666140616125446
Keywords
Fate; immunomodulation; mesenchymal stem cells (MSCs); secretive factors; transplantation
Categories
Funding
- Hong Kong Government Research Grant Council, General Research Fund [CUHK470813]
- China Shenzhen City Science and Technology Bureau under the Shenzhen City Knowledge Innovation Plan, Basic Research Project [JCYJ20130401171935811]
- SMART program, Lui Che Woo Institute of Innovative Medicine, Faculty of Medicine, The Chinese University of Hong Kong
Ask authors/readers for more resources
Mesenchymal stem cells (MSCs) are multi-potent cells which have been widely used for tissue regeneration and immunomodulation. The infusion of autologous and allogenic MSCs has been proved to be safe and effective in tissue repair and disease modulation. The inherent homing ability of MSCs ensures the transplanted cells migrating into the damaged tissue areas, but only a small percentage of the transplanted (allogenic) MSCs survive for long. However, the beneficial effects of MSCs transplantation could be noted within 1-2 days that are unlikely due to their proliferation and differentiation. The regulatory roles of MSCs in tissue repair are rather more important than their direct involvement of repair processes. The most important effect of transplanted MSCs is their immunomodulation function through crosstalk with the immune cells or the paracrine actions. The active factor secreted by MSCs may vary in the different disease conditions or tissue niches, and are under dynamic changes in various local environments. To understand and define the MSCs secretion factors in various disease settings could be a future research direction, and the findings could lead to potential new MSCs-based therapeutic products.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available